Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark...
Kimberly-Clark CEO Mike Hsu told CNBC’s Jim Cramer that his company’s planned acquisition of Tylenol maker Kenvue will create value for shareholders, even as the pain...
Huggies, manufactured by Kimberly-Clark and Band-Aid, manufactured by Kenvue. Getty Images Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at...
Trading information on Kenvue Inc., a consumer-health business spun off from Johnson & Johnson, is displayed on a screen during the company’s IPO at the New...
